Response to Chimeric Antigen Receptor (CAR)-T Cells Therapy in Patients With Hematologic Malignancies Depending on Tumor Characteristics
Clinical trial NCT04209829 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04209829
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-01
- Primary completion
- 2025-03-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.